ANIK
Anika Therapeutics·NASDAQ
--
--(--)
--
--(--)
ANIK fundamentals
Anika Therapeutics (ANIK) Revenue Breakdown: Q3 2025 Business & Regional Performance
Anika Therapeutics (ANIK) reported total revenue of 27.82M USD in Q3 2025, with its core business segment Original Equipment Manufacturer Channel contributing 56.96%. Regionally, United States remained the largest market, accounting for 62.72% of total revenue. Explore Anika Therapeutics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Anika Therapeutics (ANIK) reported total revenue of 27.82M USD in Q3 2025, with its core business segment Original Equipment Manufacturer Channel contributing 56.96%. Regionally, United States remained the largest market, accounting for 62.72% of total revenue. Explore Anika Therapeutics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What were the key takeaways from Anika Therapeutics’s earnings call?What is the revenue and EPS growth rate for Anika Therapeutics year over year?What is Anika Therapeutics's latest dividend and current dividend yield?What does Anika Therapeutics do and what are its main business segments?What factors drove the changes in Anika Therapeutics's revenue and profit?What were the key takeaways from Anika Therapeutics's earnings call?What is the market's earnings forecast for Anika Therapeutics next quarter?What guidance did Anika Therapeutics's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
